116 related articles for article (PubMed ID: 15850612)
1. Acquired factor V inhibitor and single exposure to autologous growth factor.
Shah AK; Moreno-Aspitia A
Thromb Res; 2005; 116(1):87-9. PubMed ID: 15850612
[No Abstract] [Full Text] [Related]
2. Development of cephradine-induced acquired factor V inhibitors: a case report.
Wu MT; Pei SN
Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
[TBL] [Abstract][Full Text] [Related]
3. [Acquired factor V inhibitor treated with intravenous immunoglobulins].
Buclin T; Schmidt PM; Hauert J; Winkel L; Chapuis G; Bachmann F
Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1968-70. PubMed ID: 1475662
[TBL] [Abstract][Full Text] [Related]
4. Factor V inhibitor: case report.
Leus B; Devreese K; van den Bossche J; Malfait R
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):585-7. PubMed ID: 16988556
[TBL] [Abstract][Full Text] [Related]
5. A case report of an acquired inhibitor to coagulation factor V.
Shanmugam H; Jayaranee S; Eow GI
Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356
[No Abstract] [Full Text] [Related]
6. Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.
Wang X; Qin X; Yu Y; Wang R; Liu X; Ji M; Zhou M; Chen C
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):334-341. PubMed ID: 27428013
[TBL] [Abstract][Full Text] [Related]
7. [Acquired inhibitor to coagulation factor V].
Takahashi I
Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):506-8. PubMed ID: 9833556
[No Abstract] [Full Text] [Related]
8. [Simultaneous development of factor V inhibitor and autoimmune thrombocytopenia in a patient with dermatomyositis].
Takaku T; Kuriyama Y; Shoji N; Otawa M; Gotoh A; Miyazawa K; Fukutake K; Ohyashiki K
Rinsho Ketsueki; 2002 Dec; 43(12):1050-4. PubMed ID: 12607994
[TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
10. Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
Ahmadinejad M; Roushan N
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):97-9. PubMed ID: 23080366
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
Borucki K; Töpfer G; Hartung KJ; Lutze G
Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
[TBL] [Abstract][Full Text] [Related]
12. [Factor V inhibitor with double cancer].
Okajima A; Horii J; Nasu K; Niki Y; Akasaka K; Yamashita H; Sugimoto M; Yoshioka A
Rinsho Ketsueki; 1989 Apr; 30(4):514-9. PubMed ID: 2769972
[TBL] [Abstract][Full Text] [Related]
13. Haemodialysis Tunisian patient with acquired factor V inhibitor associated to arteriovenous shunt thrombosis.
Ghachem I; El Borgi W; Fekih Salem S; Ben Lakhal F; Chelbi A; Ghiriani I; Gouider E
Ann Biol Clin (Paris); 2020 Apr; 78(2):206-209. PubMed ID: 32319951
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma.
Maughan EO; Wilson J; Wilde JT
Int J Lab Hematol; 2007 Aug; 29(4):316-9. PubMed ID: 17617083
[TBL] [Abstract][Full Text] [Related]
15. Acquired factor V inhibitor after haematopoietic stem cell transplantation.
Milojkovic D; Patel R; Ford E; Arya R; Mufti G
Thromb Haemost; 2007 Sep; 98(3):685-7. PubMed ID: 17849062
[No Abstract] [Full Text] [Related]
16. Severe bleeding caused by an inhibitor to coagulation factor V: a case report.
Smid WM; de Wolf JT; Nijland JH; Bom VJ; van der Meer J
Blood Coagul Fibrinolysis; 1994 Feb; 5(1):133-7. PubMed ID: 8180333
[TBL] [Abstract][Full Text] [Related]
17. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
[TBL] [Abstract][Full Text] [Related]
18. The diversity in clinical presentation of acquired factor V inhibitor. Two case reports.
Gadelha T; Aquino JH; Assunção e Silva E; Santos FL; de Oliveira MH
Acta Haematol; 2008; 119(2):108-10. PubMed ID: 18367830
[No Abstract] [Full Text] [Related]
19. [Factor V inhibitor developing in a patient with pulmonary tuberculosis (author's transl)].
Takase T; Fujimura Y; Mikami S; Fukui H; Fukui H; Tsujii T; Hashimoto A
Rinsho Ketsueki; 1980 Jul; 21(7):1038-46. PubMed ID: 7420740
[No Abstract] [Full Text] [Related]
20. Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.
Savage WJ; Kickler TS; Takemoto CM
Pediatr Blood Cancer; 2007 Dec; 49(7):1025-9. PubMed ID: 16526049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
